Avid Bioservices (CDMO) Misses Q1 EPS by 1c, beats revenue, offers guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/8/2026
- Wall St set to open lower as oil jump, high yields fuel inflation concerns
- Oil jumps as Middle East supply concerns persist amid shipping attacks
- Why Citi says the Fed could be setting up for a dovish surprise
- Alphabet shares rise as Google pushes Gemini deeper into enterprise AI
- Lynx sees AI semiconductor rally extending into year-end
Tweet
Share
E-mailGet Alerts CDMO Hot Sheet
Join SI Premium – FREE
Avid Bioservices (NASDAQ: CDMO) reported Q1 EPS of ($0.03), $0.01 worse than the analyst estimate of ($0.02). Revenue for the quarter came in at $37.7 million versus the consensus estimate of $37.06 million.
GUIDANCE:
Avid Bioservices sees FY 2024 revenue of $145-165 million.
For earnings history and earnings-related data on Avid Bioservices (CDMO) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Novagold Resources, Inc. (NG) Misses Q3 EPS by 2c
- PepsiCo shares climb after Q3 beat, though company trims profit forecast
- Apogee Enterprises (APOG) Tops Q2 EPS by 54c ; Offers Guidance
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
